321 related articles for article (PubMed ID: 24742800)
1. Sarcolemmal alpha and gamma sarcoglycan protein deficiencies in Turkish siblings with a novel missense mutation in the alpha sarcoglycan gene.
Diniz G; Tosun Yildirim H; Akinci G; Hazan F; Ozturk A; Yararbas K; Tukun A
Pediatr Neurol; 2014 Jun; 50(6):640-7. PubMed ID: 24742800
[TBL] [Abstract][Full Text] [Related]
2. The first case of primary alpha-sarcoglycanopathy identified in Albania, in two siblings with homozygous alpha-sarcoglycan mutation.
Babameto-Laku A; Tabaku M; Tashko V; Cikuli M; Mokini V
Genet Couns; 2011; 22(4):377-83. PubMed ID: 22303798
[TBL] [Abstract][Full Text] [Related]
3. Histopathological and genetic features of patients with limb girdle muscular dystrophy type 2C.
Dınız G; Hazan F; Yildirim HT; Unalp A; Polat M; Serdaroğlu G; Güzel O; Bağ O; Seçıl Y; Ozgönül F; Türe S; Akhan G; Tükün A
Turk Patoloji Derg; 2014; 30(2):111-7. PubMed ID: 24638197
[TBL] [Abstract][Full Text] [Related]
4. Concomitant alpha- and gamma-sarcoglycan deficiencies in a Turkish boy with a novel deletion in the alpha-sarcoglycan gene.
Diniz G; Tosun Yildirim H; Gokben S; Serdaroglu G; Hazan F; Yararbas K; Tukun A
Case Rep Genet; 2014; 2014():248561. PubMed ID: 25050186
[TBL] [Abstract][Full Text] [Related]
5. A novel mutation in alpha sarcoglycan gene in an Iranian family with limb girdle muscular dystrophy 2D.
Mojbafan M; Nilipour Y; Tonekaboni SH; Tavakkoly-Bazzaz J; Zeinali S
Neurol Res; 2016 Mar; 38(3):220-3. PubMed ID: 27093116
[TBL] [Abstract][Full Text] [Related]
6. Very late-onset limb-girdle muscular dystrophy type 2D: A milder form with a normal muscle biopsy.
Oliveira Santos M; Coelho P; Roque R; Conceição I
J Clin Neurosci; 2020 Feb; 72():471-473. PubMed ID: 31836381
[TBL] [Abstract][Full Text] [Related]
7. Sarcoglycanopathies: can muscle immunoanalysis predict the genotype?
Klinge L; Dekomien G; Aboumousa A; Charlton R; Epplen JT; Barresi R; Bushby K; Straub V
Neuromuscul Disord; 2008 Dec; 18(12):934-41. PubMed ID: 18996010
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of sarcoglycans, vinculin-talin-integrin system and filamin2 in alpha- and gamma-sarcoglycanopathy: an immunohistochemical study.
Anastasi G; Cutroneo G; Trimarchi F; Santoro G; Bruschetta D; Bramanti P; Pisani A; Favaloro A
Int J Mol Med; 2004 Dec; 14(6):989-99. PubMed ID: 15547664
[TBL] [Abstract][Full Text] [Related]
9. Beta-sarcoglycan gene mutations in Turkey.
Balci B; Wilichowski E; Haliloğlu G; Talim B; Aurino S; Kremer E; Ebinger F; Senbil N; Anlar B; Kale G; Nigro V; Topaloğlu H; Bonnemann C; Dinçer P
Acta Myol; 2004 Dec; 23(3):154-8. PubMed ID: 15938573
[TBL] [Abstract][Full Text] [Related]
10. Mutations in the delta-sarcoglycan gene are a rare cause of autosomal recessive limb-girdle muscular dystrophy (LGMD2).
Duggan DJ; Manchester D; Stears KP; Mathews DJ; Hart C; Hoffman EP
Neurogenetics; 1997 May; 1(1):49-58. PubMed ID: 10735275
[TBL] [Abstract][Full Text] [Related]
11. [The frequency of patients with adhalin deficiency in a muscular dystrophy patient population].
Hayashi YK; Arahata K
Nihon Rinsho; 1997 Dec; 55(12):3165-8. PubMed ID: 9436429
[TBL] [Abstract][Full Text] [Related]
12. Novel mutations in three patients with LGMD2C with phenotypic differences.
Vermeer S; Verrips A; Willemsen MA; ter Laak HJ; Ginjaar IB; Hamel BC
Pediatr Neurol; 2004 Apr; 30(4):291-4. PubMed ID: 15087111
[TBL] [Abstract][Full Text] [Related]
13. [Gene analysis in patients with muscular dystrophy: alpha-sarcoglycan (adhalin) gene mutations in patients with malignant limb-girdle muscular dystrophy].
Akaike M; Kawai H
Rinsho Byori; 1997 Feb; 45(2):136-40. PubMed ID: 9120997
[TBL] [Abstract][Full Text] [Related]
14. Different outcome of sarcoglycan missense mutation between human and mouse.
Henriques SF; Patissier C; Bourg N; Fecchio C; Sandona D; Marsolier J; Richard I
PLoS One; 2018; 13(1):e0191274. PubMed ID: 29360879
[TBL] [Abstract][Full Text] [Related]
15. Deficiency of the 50 kDa dystrophin-associated-glycoprotein (adhalin) in an Indian autosomal recessive limb girdle muscular dystrophy patient : immunochemical analysis and clinical aspects.
Handa V; Mital A; Gupta M; Goyle S
Neurol India; 2001 Mar; 49(1):19-24. PubMed ID: 11303236
[TBL] [Abstract][Full Text] [Related]
16. Genomic screening for beta-sarcoglycan gene mutations: missense mutations may cause severe limb-girdle muscular dystrophy type 2E (LGMD 2E).
Bönnemann CG; Passos-Bueno MR; McNally EM; Vainzof M; de Sá Moreira E; Marie SK; Pavanello RC; Noguchi S; Ozawa E; Zatz M; Kunkel LM
Hum Mol Genet; 1996 Dec; 5(12):1953-61. PubMed ID: 8968749
[TBL] [Abstract][Full Text] [Related]
17. Revised spectrum of mutations in sarcoglycanopathies.
Trabelsi M; Kavian N; Daoud F; Commere V; Deburgrave N; Beugnet C; Llense S; Barbot JC; Vasson A; Kaplan JC; Leturcq F; Chelly J
Eur J Hum Genet; 2008 Jul; 16(7):793-803. PubMed ID: 18285821
[TBL] [Abstract][Full Text] [Related]
18. Genetic heterogeneity within a consanguineous family involving the LGMD 2D and the LGMD 2C genes.
Fendri K; Kefi M; Hentati F; Amouri R
Neuromuscul Disord; 2006 May; 16(5):316-20. PubMed ID: 16616845
[TBL] [Abstract][Full Text] [Related]
19. Probable high prevalence of limb-girdle muscular dystrophy type 2D in Taiwan.
Liang WC; Chou PC; Hung CC; Su YN; Kan TM; Chen WZ; Hayashi YK; Nishino I; Jong YJ
J Neurol Sci; 2016 Mar; 362():304-8. PubMed ID: 26944168
[TBL] [Abstract][Full Text] [Related]
20. Repairing folding-defective α-sarcoglycan mutants by CFTR correctors, a potential therapy for limb-girdle muscular dystrophy 2D.
Carotti M; Marsolier J; Soardi M; Bianchini E; Gomiero C; Fecchio C; Henriques SF; Betto R; Sacchetto R; Richard I; Sandonà D
Hum Mol Genet; 2018 Mar; 27(6):969-984. PubMed ID: 29351619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
